References
- Kyle R.A. Multiple myeloma: Review of 869 Cases. Mayo Clin. Proc 1975; 50: 29–40
- Suchman A.L., Coleman M., Mouradian J.A., Wolf D.S., Saletan S. Aggressive plasma cell myeloma: A terminal phase. Arch. Intern. Med 1981; 141: 1315–1320
- Falini B., De Solas I., Levine A.M., Parker J.W., Lukes R.J., Taylor C.R. Emergence of B-Immunoblastic sarcoma in patients with multiple myeloma: A clinicopathologic study of 10 cases. Blood 1982; 59: 923–933
- Foucar K., Raber M., Foucar E., Barlogie B., Sandler C.M., Alexanian R. Anaplastic myeloma with massive ex-tramedullary involvement. Report of two cases. Cancer 1983; 51: 166–174
- Bergsagel D.E., Prusanski W. Treatment of plasma cell myeloma with cytotoxic agents. Arch. Intern. Med. 1975; 135: 172–176
- Strand W.R., Banks P.M., Kyle R.A. Anaplastic plasma cell myeloma and immunoblastic lymphoma. Clinical, pathologic and immunologic comparison. Am. J. Med. 1984; 76: 861–867
- Thomsen H.S., Dorph S. The upper urinary tract pyelography and interventional procedures. Acta Radiol. 1987; 28: 129–137
- Cordell J.L., Falini B., Erber W.N., Ghosh A.K., Abdulaziz Z., MacDonald S., Pulford K.A.P., Stern H., Mason D.Y. Immunoenzymatic labeling of monoclonal andibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes. J. Histochem. Cytochem. 1984; 32: 219–229
- Richter M.N. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am. J. Path. 1928; 4: 285–292
- Harousseau J.L., Flandrin G., Tricot G., Brouet J.C., Seligmann M., Bernard J. Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: A Study of 25 Cases. Cancer 1981; 48: 1302–1308
- DiStasi M., Cavanna L., Paties C., Formani F., Civardi G., Binelli F., Buscarini E., Buscarini L. Anaplastic myeloma as extramedullary relapse of multiple myeloma in remission. Acta Haemat. 1986; 76: 202–207
- Woodruff R.K., Whittle J.M., Malpas J.S. Solitary plasmacytoma I: Extramedullary soft tissue plasmacytoma. Cancer 1979; 43: 2340–2343
- Medini E., Rao Y., Levitt S.H. Solitary extramedullary plasmacytoma of the upper respiratory and digestive tracts. Cancer 1980; 45: 2893–2896
- Meis J.M., Butler J.J., Osborne B.M., Ordonez N.G. Solitary plasmacytomas of bone and extramedullary plasmacytomas. A clinicopathologic and immunohistochemical study. Cancer 1987; 59: 1475–1485
- Holt J.M., Robb-Smith A.H.T. Multiple myeloma: development of plasma cell sarcoma during apparently successful chemotherapy. J. Clin. Path. 1973; 26: 649–659
- Durie B.G.M. Is myeloma really a monoclonal disease?. Br. J. Haematol. 1984; 57: 357–363
- Durie B.G.M. The biology of multiple myeloma. Hematol. Oncol. 1988; 6: 77–81
- Durie B.G.M. Staging and kinetics of multiple myeloma. Sem. Oncol. 1986; 13: 300–309
- Durie B.G.M., Grogan T.M. CALLA positive myeloma: an aggressive subtype with poor survival. Blood 1985; 66: 229–232
- Epstein J., Barlogie B., Katzmann J., Alexanian R. Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood 1988; 71: 861–865
- Lokhorst H.M., Dekker A.W., Baarlen J.V., Bast E. J. E. G. J Chain Disease: An aggressive evolution of Multiple Myeloma. Amer. J. Medic 1990; 88: 417–420